Evidence map›Paper›PMID 41746533›Full record

Trial reportBreast cancer research and treatment2026

Effect of a supervised intermittent exercise program on insomnia in breast cancer patients undergoing chemotherapy.

Chloé Drozd, Elsa Curtit, Quentin Jacquinot, Pauline Roux, Sophie Paget-Bailly, Valérie Gillet, Nathalie Meneveau, Fabienne Mougin

Registry-linked trialAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Breast cancer research and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04867096 (Effects of a Supervised Exercise on Sleep in Patients With Non Metastatic Breast Cancer During Chemotherapy), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04867096 naunknown statusnot on this map

Effects of a Supervised Exercise on Sleep in Patients With Non Metastatic Breast Cancer During Chemotherapy

TypeinterventionalSponsorCentre Hospitalier Universitaire de BesanconRan2021 to 2023Enrolled60ConditionsBreast CancerArmsPhysical activity
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chloé DrozdUniversité Marie et Louis Pasteur, SINERGIES (UR 4662), F-25000, Besançon, France. chloe.drozd@hotmail.fr.
Elsa CurtitUniversité Marie et Louis Pasteur, INSERM U1098 RIGHT, F-25000, Besançon, France.
Quentin JacquinotUniversité Marie et Louis Pasteur, SINERGIES (UR 4662), F-25000, Besançon, France.
Pauline RouxService de Physiologie - Explorations fonctionnelles, CHU Jean Minjoz, F-25000, Besançon, France.
Sophie Paget-BaillyUniversité Marie et Louis Pasteur, INSERM U1098 RIGHT, F-25000, Besançon, France.
Valérie GilletCentre Médical Santé Sommeil - Ellipse, Association le Don Du Souffle, F-25000, Besançon, France.
Nathalie MeneveauInstitut Régional Fédératif du Cancer de Franche-Comté, F-25000, Besançon, France.
Fabienne MouginUniversité Marie et Louis Pasteur, SINERGIES (UR 4662), F-25000, Besançon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with localized breast cancer receiving adjuvant chemotherapy often experience sleep disturbances, especially insomnia, which significantly impacts quality of life. This study primarily aimed to evaluate the effects of a 12-week exercise program on insomnia, with secondary outcomes on sleep quality, anxiety/depression, fatigue, pain, and exercise adaptation.

methodsIn this randomized controlled multicenter trial, 20 women with non-metastatic breast cancer and clinically diagnosed insomnia were assigned to a control or training group. The training group underwent a 12-week supervised intermittent aerobic exercise program during chemotherapy. The primary outcome was objective total sleep time; secondary outcomes included insomnia severity, sleep architecture, sleep quality, anxiety/depression, fatigue, pain, and cardiorespiratory capacity. Assessments were performed before chemotherapy (T-1), at baseline (T0), and post-intervention (T3) using polysomnography, actigraphy, validated questionnaires, and a maximal graded exercise test.

resultsThe prevalence of clinical insomnia increased from 47% before diagnosis to 71% at T-1, reaching 100% at T0. Total sleep time did not increase after training (p = 0.97), although sleep fragmentation decreased. Clinical improvement was observed in physical and activity-related fatigue. Finally, both submaximal exercise adaptation parameters (power and VO

conclusionsThe training did not increase total sleep time, likely due to insomnia's multifactorial origin. However, training yielded beneficial effects on objective sleep quality and exercise-induced adaptation. Future research is needed to investigate the various etiologies of insomnia to develop tailored and personalized management approaches. CLINICAL TRIALS NUMBER: NCT04867096.

Indexed as

Breast NeoplasmsExercise TherapySleep Initiation and Maintenance DisordersAdultAgedExerciseFemaleHumansMiddle AgedQuality of LifeSleep QualityTreatment OutcomeBreast cancerInsomniaPhysical trainingSleep disorders

Identifiers

PMID41746533
PMCPMC12945910

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.